Featured

LGP, which shared proceeds of the deal with SRS employees, also wins PE Hub's Large-Cap North America Deal of the Year Award.

As well as entering the US market through M&A, the seven-year hold let Permira cash in on the rapid growth of the alternatives industry.

Atlas saw a ripe opportunity to exit an eight-year hold of a printer labels manufacturing business sold in two pieces in late 2024.

Supply chain disruption during the covid-19 pandemic and a drop in customer inventory levels late in the hold period didn't stop Walki, a packaging materials manufacturer, growing its EBITDA multiple.

SWDP's revenue grew 5x and EBITDA 7x through Montage's hold, thanks to initiatives like the creation of an installation division and the backdrop of the data center boom.

The Paris Olympics in 2024 proved good timing for Nutripure, as the company created a dedicated communication strategy around the event.

The consulting company has just released its Global Private Equity Report 2025.

Avista Healthcare Partners, BC Partners, Hamilton Lane and Kartesia are among the PE firms investing in the generic pharmaceutical sector.

PSG Equity is selling a majority stake it bought in 2019.

Lion Capital, Purchase Capital and Riverside were all involved in franchise deals in February.